Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Solaray Launches UNLIMIT, a Full Product Line Built for Longevity

Solaray

News provided by

Solaray

Jul 20, 2026, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Anchored by Creatine + MBP, NMN, and Liposomal NAD+, the eight-formula system is designed to support the 75 percent of aging influenced by how we live, train, and fuel our bodies

SALT LAKE CITY, July 20, 2026 /PRNewswire/ -- Solaray®, a trusted leader in high-quality, rigorously tested supplements, today introduces UNLIMIT, a new eight-product system built to support how the body performs and functions over time, with a focused approach grounded in three of the most relevant areas of longevity: cellular energy, muscle health, and bone density.*

Continue Reading
Hero image of Solaray's UNLIMIT collection, featuring NAD+, NMN and Creatine + MBP
Hero image of Solaray's UNLIMIT collection, featuring NAD+, NMN and Creatine + MBP

UNLIMIT is led by three hero formulas: Creatine + MBP®, formulated to support muscle and bone health in aging; NMN, formulated at a clinically studied dose to increase NAD+ levels; and Liposomal NAD+, formulated to support cellular energy.* Together, these formulas target key indicators researchers point to when describing how the body changes with age and reflect Solaray's approach of pairing proven ingredients with thoughtful delivery science rather than chasing trend-driven formulas.

Research suggests that genetics account for approximately 25% of the variation in how people age, while lifestyle and environmental factors influence the remaining 75%.*

Designed with that understanding in mind, Solaray developed UNLIMIT as one of the only full, targeted longevity-focused supplement systems in the market. The line includes eight complementary formulas that support both macro aspects of health, like muscle and bone, and cellular-level function.

Introducing the UNLIMIT Line

UNLIMIT brings together eight formulas, each chosen to support a specific, well-documented aspect of how the body functions and changes with age, without unnecessary ingredients or overengineered formulas.

"UNLIMIT was designed to simplify a complex category," said Rachel Kilroy, Sr. Director of Product Innovation at Solaray. "As the science around longevity has evolved, research has continued to point to the importance of supporting muscle, bone, and cellular health. We created UNLIMIT as a collection of targeted supplements rooted in these key areas, giving consumers a practical way to take a more focused approach to healthy aging. To us, longevity isn't about living longer. It's about feeling your best and maintaining that vitality throughout the years ahead."

At the center of the lineup are three hero formulas:

  • Creatine + MBP, an unflavored powder combining 8 grams of creatine monohydrate to support muscle health in aging, muscle growth, and exercise recovery, with 40 milligrams of MBP, a clinically studied ingredient shown to support bone mineral density in women, plus 500 milligrams of L-leucine for additional targeted support.*
  • NMN is formulated at a clinically studied dose to increase NAD+ levels; NAD+ supports cellular energy, helping support cellular health as the body ages.*
  • Liposomal NAD+, a 500 milligram formula using liposomal technology designed for optimal absorption, supporting cellular energy as NAD+ levels naturally decline with age.*

Together, these three formulas reflect Solaray's approach: pairing well-established ingredients with thoughtful delivery systems to support key indicators of healthy aging, from muscle and bone health to cellular function.*

The hero trio is complemented by five additional formulas that complete the system:

  • Liposomal Glutathione, an antioxidant formula designed to support cellular health, immune function, and the body's natural detoxification processes.*
  • PEAK ATP®, a clinically studied ingredient that supports physical performance, energy for exercise, and muscle function.*
  • Spermidine, a naturally occurring polyamine at a clinically studied dose to help maintain healthy levels.*  .*
  • Fisetin, a plant-derived flavonoid formulated to help maintain healthy levels.*
  • NADH, a vital coenzyme that supports cellular energy for support at the cellular level.*

Each product is designed to work on its own or as part of a broader routine, giving consumers flexibility to build a personalized approach to supporting long-term health and performance.

Built On Solaray's Legacy of Trust

Every UNLIMIT formula is manufactured in Solaray's GMP-certified facility with ingredients that are triple-tested for identity, purity, and potency, the same standard the brand has applied for more than five decades. Through its vertically integrated model, Solaray maintains oversight from formulation through manufacturing and testing, allowing the brand to pair innovation with the quality standards consumers have trusted since 1973. The UNLIMIT line reflects Solaray's long-standing philosophy: no unnecessary ingredients, no overengineered formulas, and a focus on delivering targeted support people can use consistently over time.

UNLIMIT is now available at Solaray.com, Amazon.com, and participating health food stores nationwide.

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

*SOURCE: https://pmc.ncbi.nlm.nih.gov/articles/PMC9145989/
Caruso C, et. al. How Important Are Genes to Achieve Longevity? International Journal of Molecular Science 2022 May PMC9145989. 

About Solaray

Since 1973, Solaray has scoured the globe for the highest-quality ingredients, connecting you with the most efficacious supplements that help you Live Brighter and embrace the moments that matter most. We pride ourselves on a more than 50-year legacy of award-winning innovation and industry-leading quality that continues today. We offer more than 700 science-backed, cutting-edge products—nearly every vitamin, mineral, and herb under the sun—each ingredient rigorously quality tested for identity, purity, and potency in our state-of-the-art cGMP and ISO Certified lab in the beautiful mountains of Utah. Solaray was built upon the belief that nature is the source of wellness, and our outlook hasn't changed. For more information and to purchase products, please visit Solaray online at Solaray.com, or on Facebook and Instagram.

SOURCE Solaray

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Solaray Launches Liposomal Prenatal to Redefine Daily Nutrition for Moms-to-Be

Solaray Launches Liposomal Prenatal to Redefine Daily Nutrition for Moms-to-Be

In celebration of National Women's Health Month, Solaray®, a trusted leader in high‑quality, rigorously tested supplements, today introduced its new...

Magnesium Meets Innovation: Solaray Debuts Personalized Combos for Sleep, Stress and Peak Performance

Magnesium Meets Innovation: Solaray Debuts Personalized Combos for Sleep, Stress and Peak Performance

Solaray, a premium supplement brand with high quality formulas, today introduced new products to its category-leading magnesium portfolio. The new...

More Releases From This Source

Explore

Supplementary Medicine

Supplementary Medicine

Retail

Retail

Health Care & Hospitals

Health Care & Hospitals

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.